Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSearching for a Mounjaro multipack usually comes from a reasonable instinct — you're partway through treatment, it's working, and buying in bulk feels sensible. The short answer is that Mounjaro is supplied as a single KwikPen containing four weekly doses, so the pen is your month's supply. There is no separately marketed multipack product. As a prescription-only medicine, every supply requires a clinical assessment by a registered prescriber, which shapes how quantity and timing work in practice. Here's what you need to know.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a very common assumption. If a supplement or over-the-counter medicine works well, you buy three months' worth and save yourself the hassle. Mounjaro doesn't follow that logic, and it's worth understanding why before you spend time hunting for a deal that doesn't exist.
Mounjaro (tirzepatide) is manufactured by Eli Lilly as a pre-filled KwikPen. Each pen contains four doses (one per week) so a single pen is already your monthly supply. Lilly does not produce or authorise a separately packaged multipack format in the UK. What you might see described as a multipack online is simply more than one pen supplied at the same time, which can happen, but only following a clinical prescription that specifies it.
The deeper point is that tirzepatide is a Prescription-Only Medicine (POM). A prescriber must review your situation (current dose, tolerability, weight progress) before any supply is issued or renewed. That applies whether you're receiving one pen or four. The quantity isn't a commercial decision; it's a clinical one. The full tirzepatide treatment overview explains how this works across the different UK-licensed dose strengths.
A quick thing worth doing right now: if you've seen a listing claiming to sell Mounjaro multipacks without a prescription, check the seller against the GPhC pharmacy register at pharmacyregulation.org/registers. It takes under a minute, and if the pharmacy isn't listed, that tells you everything.
Treatment with Mounjaro starts at 2.5mg. That first pen exists primarily to let your system adjust, the GI side effects that catch some people off-guard (nausea, loose stools, the occasional early-morning queasiness) tend to be most noticeable in the first weeks and settle as the body adapts. After four weeks, most prescribers move patients up by one strength if the lower dose is well tolerated.
The licensed UK strengths run from 2.5mg to 15mg in 2.5mg steps. A prescriber tracking your progress over several months may, at a review, supply more than one pen at a time, particularly once you've reached a stable maintenance dose. But that decision follows a clinical re-review, not an automatic repeat. At nume, every repeat order goes back in front of a GPhC-registered Independent Prescriber before anything is dispatched. A real clinician reads your update the same day, never an automated process.
This also means that if you're hoping to jump ahead to a higher-dose pen because you've heard results improve at 10mg or 15mg, a prescriber won't support that without evidence of how you've tolerated the steps below it. The titration schedule protects you from unnecessary side effects, not just regulatory box-ticking. The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed average body-weight reductions of around 20–21% at the 15mg dose over 72 weeks, but those results followed the full titration programme, not a skip to the top.
If you're thinking about a multipack primarily because it might be cheaper per pen, it's useful to understand how pricing actually works for a POM. For context, Eli Lilly raised Mounjaro's UK list price from 1 September 2025, and you can see how that affects what you pay at each dose strength on our page covering current Mounjaro prices across the available options. You can find a fuller breakdown on the Mounjaro price comparison page.
What headline prices sometimes leave out: consultation fees, prescription charges, delivery, and whether ongoing clinical review is included or billed separately. A seemingly low per-pen figure can climb quickly once those are added. At nume, one transparent price covers the consultation, the prescription, the treatment, and free next-working-day tracked delivery, with 7-day aftercare included. No subscription, no hidden renewal. Deliberately not the cheapest option on the market; what that buys you is a properly supervised clinical pathway.
For anyone considering how Mounjaro packing and supply works in practice, the key question isn't how many pens you can get at once, it's whether each supply is backed by a clinical review that's keeping your treatment on track. That's the thing that actually protects results and safety over the long term.
One consequence of treatment that often surprises people: appetite falls sharply, sometimes dramatically, and food intake drops with it. For most people that's the point, but it does mean overall nutrient intake can fall too. Protein in particular matters, both for preserving lean muscle and for feeling stable day to day.
This is why questions about vitamins and supplements come up so frequently alongside Mounjaro. There's no single required supplement for everyone on tirzepatide, and your prescriber is the right person to advise based on your diet and health picture. But the question is a legitimate one, and if you're eating significantly less than before, it's worth raising at your next review. Our page on which multivitamins are most relevant during Mounjaro treatment covers the common considerations in more detail.
The NHS's guidance on tirzepatide on the NHS medicines pages is also a solid reference for understanding how the medicine works and what to watch for, written in plain language and kept up to date. If you have specific health conditions and want to understand how they interact with treatment, our guidance on using Mounjaro alongside multiple sclerosis is one example of the condition-specific information we provide. If you have questions about your current treatment or want to explore whether Mounjaro is right for you, speaking to a prescriber is the right next step.
Ready to get a clinical opinion? Speak to our prescribers through a free consultation, reviewed the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.